# | ||||
---|---|---|---|---|
1 | NGIN Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies | 2008 | 10˙148˙011.00 | 7˙534˙742.00 |
2 | PERSIST Persisting Transgenesis | 2009 | 14˙731˙788.00 | 11˙181˙411.00 |
3 | TB PAN-NET Pan-European network for the study and clinical management of drug resistant tuberculosis | 2009 | 14˙115˙409.00 | 10˙998˙270.00 |
4 | NABATIVI "Novel Approaches to Bacterial Target Identification, Validation and Inhibition" | 2009 | 7˙131˙835.00 | 5˙506˙000.00 |
5 | TARGETINGGENETHERAPY Towards Safe and Effective Hematopoietic Stem Cell Gene Therapy: Targeting Integration to Genomic Safe Harbors and Exploiting Endogenous microRNA to Regulate Transgene Expression | 2010 | 2˙500˙000.00 | 2˙500˙000.00 |
6 | CELL-PID Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency | 2010 | 15˙799˙071.00 | 11˙887˙735.00 |
7 | INVEST INternational VEnue for poSTgraduate education | 2011 | 2˙323˙060.00 | 929˙224.00 |
8 | IVM-VIRUS-NAB In vivo dynamics of antibody responses to lymph-borne viruses | 2012 | 1˙934˙200.00 | 1˙934˙200.00 |
9 | NONLIN-KB """Role of Nonlinear Dynamics of NF-kB in Inflammation""" | 2012 | 185˙763.00 | 185˙763.00 |
10 | SMT OF TFS Quantifying transcription factor search mechanism by three-dimensional single molecule tracking | 2012 | 181˙084.00 | 181˙084.00 |
11 | SUPERSIST Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer | 2013 | 7˙877˙054.00 | 5˙999˙997.00 |
L'Ente universita vita-salute san raffaele partecipato anche in questi progetti.